Status:
RECRUITING
Association Between Fecal Microbiota Composition, Metabolite Concentrations, and Indoxyl Sulfate Levels
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Dysbiosis
Eligibility:
All Genders
18-80 years
Brief Summary
Gut dysbiosis is frequently characterized by decreased microbial diversity and alterations in the abundance of certain microbial species. In individuals with chronic kidney disease (CKD), dysbiosis an...
Detailed Description
Patients and Study Design Sixty HD patients will be enrolled, from dialysis unit, Renal Division of The Tungs' Taichung Metroharbour Hospital. The written informed consent to take part in the study i...
Eligibility Criteria
Inclusion
- age 18-80 years and
- diagnosed with CKD stage V
- currently receiving hemodialysis treatment\>3 months
Exclusion
- pregnant or nursing women
- patients with kidney transplant
- severe infections
- severe cardiac diseases
- liver diseases
- malignancy
- autoimmune disorders
- severe malnutrition
- consumed any type of pre-or probiotics
- had antibiotic therapy within 1 month
- diagnosed irritable bowel syndrome
- Crohn's disease
- ulcerative colitis
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06877585
Start Date
April 1 2025
End Date
December 31 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tungs' Taichung Metroharbour Hospital
Taichung, Wuqi District, Taiwan, 435